BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 30909688)

  • 1. Immunologic strategies and outcomes in ABO-incompatible living donor liver transplantation.
    Oh J; Kim JM
    Clin Mol Hepatol; 2020 Jan; 26(1):1-6. PubMed ID: 30909688
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ABO-Incompatible Living Donor Liver Transplantation with Reduced Rituximab Dose: A Retrospective Analysis of 65 Patients - Can We Fast-Track Liver Transplant Surgery and Improve Long-Term Survival?
    Hsu SC; Thorat A; Jeng LB; Li PC; Chen TH; Yang HR; Poon KS
    Ann Transplant; 2020 Sep; 25():e923502. PubMed ID: 32943600
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of ABO-incompatible grafts in living donor liver transplantation--first report from India.
    Soin AS; Raut V; Mohanka R; Rastogi A; Goja S; Balachandran M; Saigal S; Saraf N; Bhangui P; Sumana KR; Singla P; Srinivasan T; Choudhary N; Tiwari A; Raina V; Govil D; Mohan N; Vohra V
    Indian J Gastroenterol; 2014 Jan; 33(1):72-6. PubMed ID: 24369388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Single-Center Experience of ABO-Incompatible Living-Donor Liver Transplantation With a New Simplified Intravenous Immunoglobulin Protocol: A Propensity Score-Matching Analysis.
    Kim JD; Choi DL; Kim SG; Lee AJ
    Transplant Proc; 2016 May; 48(4):1134-8. PubMed ID: 27320573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of rituximab desensitization on blood-type-incompatible adult living donor liver transplantation: a Japanese multicenter study.
    Egawa H; Teramukai S; Haga H; Tanabe M; Mori A; Ikegami T; Kawagishi N; Ohdan H; Kasahara M; Umeshita K
    Am J Transplant; 2014 Jan; 14(1):102-14. PubMed ID: 24279828
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Splenectomy does not offer immunological benefits in ABO-incompatible liver transplantation with a preoperative rituximab.
    Raut V; Mori A; Kaido T; Ogura Y; Taku I; Nagai K; Sasaki N; Endo K; Hata T; Yagi S; Egawa H; Uemoto S
    Transplantation; 2012 Jan; 93(1):99-105. PubMed ID: 22094955
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABO-Incompatible Adult Living Donor Liver Transplantation Under the Desensitization Protocol With Rituximab.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kim WJ; Sin MH; Yoon YI; Kang WH; Kim SH; Tak EY
    Am J Transplant; 2016 Jan; 16(1):157-70. PubMed ID: 26372830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of desensitization methods: Rituximab with/without plasmapheresis in ABO-incompatible living donor liver transplantation.
    Lee EC; Kim SH; Shim JR; Park SJ
    Hepatobiliary Pancreat Dis Int; 2018 Apr; 17(2):119-125. PubMed ID: 29576278
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biliary stricture is the only concern in ABO-incompatible adult living donor liver transplantation in the rituximab era.
    Song GW; Lee SG; Hwang S; Kim KH; Ahn CS; Moon DB; Ha TY; Jung DH; Park GC; Kang SH; Jung BH; Yoon YI; Kim N
    J Hepatol; 2014 Sep; 61(3):575-82. PubMed ID: 24801413
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenge to ABO blood type barrier in living donor liver transplantation.
    Egawa H
    Hepatobiliary Pancreat Dis Int; 2020 Aug; 19(4):342-348. PubMed ID: 32665181
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feasibility of Monotherapy by Rituximab Without Additional Desensitization in ABO-incompatible Living-Donor Liver Transplantation.
    Yamamoto H; Uchida K; Kawabata S; Isono K; Miura K; Hayashida S; Oya Y; Sugawara Y; Inomata Y
    Transplantation; 2018 Jan; 102(1):97-104. PubMed ID: 28938311
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simplified protocol using rituximab and immunoglobulin for ABO-incompatible low-titre living donor liver transplantation.
    Kim SH; Lee EC; Shim JR; Park SJ
    Liver Int; 2018 May; 38(5):932-939. PubMed ID: 29053910
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABO-incompatible Living Donor Liver Transplantation With Rituximab and Total Plasma Exchange Does Not Increase Hepatocellular Carcinoma Recurrence.
    Kim JM; Kwon CHD; Joh JW; Han S; Yoo J; Kim K; Sinn DH; Choi GS; Gerber DA; Egawa H; Lee SK
    Transplantation; 2018 Oct; 102(10):1695-1701. PubMed ID: 29494419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exchange living donor liver transplantation to overcome ABO incompatibility in adult patients.
    Hwang S; Lee SG; Moon DB; Song GW; Ahn CS; Kim KH; Ha TY; Jung DH; Kim KW; Choi NK; Park GC; Yu YD; Choi YI; Park PJ; Ha HS
    Liver Transpl; 2010 Apr; 16(4):482-90. PubMed ID: 20222052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Management of ABO-incompatible living-donor liver transplantation: past and present trends.
    Raut V; Uemoto S
    Surg Today; 2011 Mar; 41(3):317-22. PubMed ID: 21365409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Case-matched comparison of ABO-incompatible and ABO-compatible living donor liver transplantation.
    Kim JM; Kwon CH; Joh JW; Han SB; Sinn DH; Choi GS; Kang ES; Lee JH; Kim GS; Lee SK
    Br J Surg; 2016 Feb; 103(3):276-83. PubMed ID: 26695115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term Outcomes of ABO-incompatible Pediatric Living Donor Liver Transplantation.
    Honda M; Sugawara Y; Kadohisa M; Shimata K; Sakisaka M; Yoshii D; Uto K; Hayashida S; Ohya Y; Yamamoto H; Yamamoto H; Inomata Y; Hibi T
    Transplantation; 2018 Oct; 102(10):1702-1709. PubMed ID: 29620615
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Results of ABO-incompatible liver transplantation using a simplified protocol at a single institution.
    Lee J; Lee JG; Lee JJ; Kim MS; Ju MK; Choi GH; Choi JS; Kim SI; Joo DJ
    Transplant Proc; 2015 Apr; 47(3):723-6. PubMed ID: 25891718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ABO-Incompatible Liver Transplantation: State of Art and Future Perspectives.
    Cheng CH; Lee CF; Wang YC; Wu TH; Wu TJ; Chou HS; Chan KM; Lee WC
    Curr Pharm Des; 2020; 26(28):3406-3417. PubMed ID: 32370710
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Section 15. A desensitizing protocol without local graft infusion therapy and splenectomy is a safe and effective method in ABO-incompatible adult LDLT.
    Song GW; Lee SG; Hwang S; Ahn CS; Kim KH; Moon DB; Ha TY; Jung DH; Park GC; Park HW; Park YH; Kang SH; Jung BH
    Transplantation; 2014 Apr; 97 Suppl 8():S59-66. PubMed ID: 24849837
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.